Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

To Assess Safety, Reactogenicity and Immunogenicity of GSK Biologicals' 10-Valent Pneumococcal Conjugate Vaccine, When co-Administered With DTPa-Combined Vaccines and MenC or Hib-MenC Vaccines During the First 6 Months of Age.

Trial Profile

To Assess Safety, Reactogenicity and Immunogenicity of GSK Biologicals' 10-Valent Pneumococcal Conjugate Vaccine, When co-Administered With DTPa-Combined Vaccines and MenC or Hib-MenC Vaccines During the First 6 Months of Age.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 06 Sep 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; DTaP-hepatitis B-poliovirus vaccine; Hib-DTaP-hepatitis B-poliovirus vaccine; Hib-meningococcal vaccine group C conjugate; Meningococcal vaccine group C conjugate; Pneumococcal 7-valent CRM197 vaccine conjugate
  • Indications Diphtheria; Haemophilus infections; Hepatitis B; Meningococcal group C infections; Pertussis; Pneumococcal infections; Poliomyelitis; Streptococcal infections; Tetanus
  • Focus Adverse reactions; Registrational
  • Acronyms 10PN-PD-DIT-011
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 28 Mar 2011 Actual initiation date of the parent trial is Jun 2006 and actual end date is Jul 2007 as reported by ClinicalTrials.gov (NCT00334334).
    • 01 Apr 2009 Results published in The Pediatric Infectious Disease Journal.
    • 09 Oct 2008 Study start date changed from June to February 2006, as reported by ClinicalTrials.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top